# Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dabrafenib-in-patients-with-brafv600e-positive-advanced-non-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | David Planchard,Tae Min Kim,Julien Mazières,Élisabeth Quoix,Gregory J. Riely,Fabrice Barlési,Pierre‐Jean Souquet,Egbert F. Smit,Harry J.M. Groen,Ronan J. Kelly,Byoung Chul Cho,Mark A. Socinski,Lini Pandite,Christine Nase,Bo Ma,Anthony M. D’Amelio,Bijoyesh Mookerjee,C. Martin Curtis,Bruce E. Johnson |
| Citations | 448 |
| DOI | 10.1016/s1470-2045(16)00077-2 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/5006181 |
| OpenAlex ID | https://openalex.org/W2335671095 |
| PMID | 27080216 |
| Type | article |
| Year | 2016 |

## Paper authors

- [David Planchard](https://scholariq.org/researchers/david-planchard/)
- [Tae Min Kim](https://scholariq.org/researchers/tae-min-kim/)
- [Julien Mazières](https://scholariq.org/researchers/julien-mazieres/)
- [Gregory J. Riely](https://scholariq.org/researchers/gregory-j-riely/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

## Paper topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [NF-κB Signaling Pathways](https://scholariq.org/topics/nf-b-signaling-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.